NMDA receptor
Showing 1 - 25 of 7,542
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Clinical-immunological Features of Anti-NMDAR Encephalitis
Active, not recruiting
- Anti NMDA Receptor Encephalitis
- Description of clinical characteristic
-
Lyon, Bron, FranceHôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
Feb 12, 2023
Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)
Recruiting
- Anti-NMDAR Encephalitis
- IA session
- Rituximab
-
Paris, FranceHôpital Necker Enfants-Malades
Oct 31, 2022
Borderline Personality Disorder Trial in Melbourne (NMDA receptor antagonist (active drug), Lactose packed capsule
Recruiting
- Borderline Personality Disorder
- NMDA receptor antagonist (active drug)
- Lactose packed capsule (inert/inactive arm)
-
Melbourne, Victoria, AustraliaMonash Alfred Psychiatry Research Centre
Sep 27, 2022
PTSD, Alzheimer, Brain Diseases Trial in Liège (Fluoroethylnormemantine (FENM))
Not yet recruiting
- PTSD
- +5 more
- Fluoroethylnormemantine (FENM)
-
Liège, BelgiumCHU of Liège - Clinical Pharmacology Unit
Jun 23, 2023
Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Nitrous Oxide, Placebo gas, MRI)
Terminated
- Depressive Disorder, Major
- Depressive Disorder, Treatment-Resistant
- Nitrous Oxide
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 29, 2021
Therapy of Anti-NMDAR Encephalitis at Diagnosis
Active, not recruiting
- Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
-
Rotterdam, NetherlandsErasmus Medical Center
Sep 4, 2023
MDD Trial in London (MIJ821)
Not yet recruiting
- Major Depressive Disorder
-
London, United KingdomParexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022
Paraneoplastic Neurologic Encephalitis and Mature Cystic
Recruiting
- Ovarian Dermoid Cyst
- Blood sample
-
Rishon LeZion, IsraelShamir medical center
Jan 23, 2022
Depression, Post Traumatic Stress Disorder Trial in Houston (Lanicemine, Placebo)
Completed
- Depression
- Post Traumatic Stress Disorder
- Lanicemine
- Placebo
-
Houston, TexasMichael E. DeBakey VA Medical Center
Aug 18, 2020
Major Depression Trial in Berlin (Placebo, Fludrocortisone, D-Cycloserine)
Completed
- Major Depression
- Placebo
- +2 more
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Jun 19, 2020
Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies
Unknown status
- Autoimmune Encephalitis
- +2 more
- Description and analysis
-
Bron, FranceHospice Civils de Lyon
Apr 6, 2020
Depression, Alcohol Dependence Trial in West Haven (Ketalar (ketamine))
Completed
- Depression
- Alcohol Dependence
- Ketalar (ketamine)
-
West Haven, ConnecticutVA CT Healthcare Systems
Mar 5, 2020
Postoperative Shivering Trial in Islamabad (Dexmedetomidine, Ketamine)
Completed
- Postoperative Shivering
-
Islamabad, Federal, PakistanPAF Hospital Islamabad
Feb 6, 2023
Liver Failure, Liver Transplant; Complications, Post Operative Pain Trial in Malatya (Low dose ketamine infusion, 0.9% NaCl
Recruiting
- Liver Failure
- +2 more
- Low dose ketamine infusion
- 0.9% NaCl infusion
-
Malatya, TurkeyInonu university
Jul 1, 2022
Psycho-social Impact of Anti-NMDAR Encephalitis
Not yet recruiting
- NMDAR Antibody-associated Auto-immune Encephalitis
- standardized and validated surveys
-
Bron, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 13, 2023
Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)
Completed
- Postoperative Pain
- Magnesium Sulfate
- normal saline isotonic solution
-
Denizli, TurkeyPamukkale Univercity Medical School
May 25, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Not yet recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Sep 4, 2023
Mental Disorder Trial in France (immunomodulatory treatment by rituximab)
Not yet recruiting
- Mental Disorder
- immunomodulatory treatment by rituximab
-
Bordeaux, France
- +8 more
Jul 7, 2023
Pharmacogenetics of Ketamine in Children
Recruiting
- Procedural Pain
-
Trieste, ItalyIRCCS Burlo Garofolo
Mar 31, 2023
Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)
Not yet recruiting
- Magnesium
- Intraoperative Analgesia
- Magnesium Sulfate
- Propofol
- (no location specified)
Nov 12, 2023
Episiotomy Wound, Pain, Procedural Trial (Magnesium sulfate)
Not yet recruiting
- Episiotomy Wound
- Pain, Procedural
- Magnesium sulfate
- (no location specified)
Jun 9, 2022
Drug-resistant Psychiatric Disorders Using Induced Pluripotent
Enrolling by invitation
- Depressive Disorder, Treatment-Resistant
-
Monza, Monza E Brianza, ItalyFondazione IRCCS San Gerardo di Monza
May 24, 2023
MDD Trial in Taichung (NMDAE, Placebo Cap)
Recruiting
- Major Depressive Disorder
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Jan 25, 2022